AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read MoreThe ISAD supports GADA’s initiative to collect global epidemiological data using appropriate instruments, which are not always readily available. This real-world data initiative should be encouraged, particularly given the significant information gaps in countries and regions with limited medical infrastructure. If you are interested in participating, please visit https://qualtrics.kcl.ac.uk/ On behalf of the Global Atopic […]
Read MoreAD hidden hematologic risk: clonal hematopoiesis of indeterminate potential (CHIP) + An unusual facial bump related to AD + Switching off selectively skin lipid synthesis: a reversible human model of ceramide depletion + Beyond the skin: suicidal risk is real in AD + Complement, an overlooked driver of Th2 Immunity in AD
Read MoreThe success of the inaugural call for the ISAD-GADA Fellowship was highlighted, with nine applicants from nine different countries (Ethiopia, Tanzania, South Africa, Brazil, the Philippines, Nepal, Nigeria, China, and Uganda). A heartfelt thank you to everyone who applied. We were genuinely encouraged by the volume and quality of submissions we received. We are delighted […]
Read MoreHow COVID Quarantine May Have Fueled Infantile AD + Hidden Signs of Pruritus in Infants with AD + From Modeling Temperature Fluctuations to Blocking TRPV1: Restoring the Skin Barrier and Treating Pruritus + Can Early Short-Term Moisturizer Use Rewrite an Infant’s Microbiome and Prevent Atopic Dermatitis? + Serine Sensing System for tracking moisturizer treatment of a patient with AD
Read MoreCrusted Scabies and Dupilumab: A Case from Brazil + Seasonal Severity of AD by Birth Season: What’s the Culprit? + Primary Atopic Disorders (PADs): When Should This Be Considered? + Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) Lower the Risk of New-Onset Atopic Dermatitis in Diabetic Patients: Another Clue in the Salt Debate? + Targeting the OX40-OX40L Pathway: A New Era in AD Management?
Read MoreCommunication from GADA Kicking off the new year with exciting news! We’re thrilled to announce the upcoming launch of the ISAD-GADA Fellowship! This program is designed to support #earlycareer #dermatologists or researchers in #epidemiology and #publichealth, providing them with the opportunity to collaborate with the GADA team, acquire valuable skills, and lead a small GADA […]
Read More